Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
July 25, 2000
[Moldavie, you said Moldavie? Planning and realization of an ECHO Program (Emergency Program of the European Union) by a group of pediatricians liberated in a country of the former USSR]
C Weisbecker
American Journal of Hospital Pharmacy
|
March 1, 1990
Cost-effective alternative to aminocaproic acid syrup
R Fiscella, F Siegel, C Weisbecker
American Journal of Hospital Pharmacy
|
January 1, 1992
Alternative solution for Opticrom
R G Fiscella, F P Siegel, C Weisbecker
Annales De Dermatologie Et De Venereologie
|
January 1, 1988
[Autoimmune pemphigus combined with alpha 1-antitrypsin deficiency]
L Vaillant, M C Weisbecker, A de Muret, et al.
Vaccine
|
December 15, 2000
A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth
R Gylca, V Gylca, O Benes, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
July 25, 2000
[Moldavie, you said Moldavie? Planning and realization of an ECHO Program (Emergency Program of the European Union) by a group of pediatricians liberated in a country of the former USSR]
C Weisbecker
American Journal of Hospital Pharmacy
|
March 1, 1990
Cost-effective alternative to aminocaproic acid syrup
R Fiscella, F Siegel, C Weisbecker
American Journal of Hospital Pharmacy
|
January 1, 1992
Alternative solution for Opticrom
R G Fiscella, F P Siegel, C Weisbecker
Annales De Dermatologie Et De Venereologie
|
January 1, 1988
[Autoimmune pemphigus combined with alpha 1-antitrypsin deficiency]
L Vaillant, M C Weisbecker, A de Muret, et al.
Vaccine
|
December 15, 2000
A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth
R Gylca, V Gylca, O Benes, et al.
Page
of 1